Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
- PMID: 9671767
- PMCID: PMC21165
- DOI: 10.1073/pnas.95.15.8847
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
Abstract
Hepatocellular carcinoma (HCC) is the major primary malignant tumor in the human liver, but the molecular changes leading to liver cell transformation remain largely unknown. The Wnt-beta-catenin pathway is activated in colon cancers and some melanoma cell lines, but has not yet been investigated in HCC. We have examined the status of the beta-catenin gene in different transgenic mouse lines of HCC obtained with the oncogenes c-myc or H-ras. Fifty percent of the hepatic tumors in these transgenic mice had activating somatic mutations within the beta-catenin gene similar to those found in colon cancers and melanomas. These alterations in the beta-catenin gene (point mutations or deletions) lead to a disregulation of the signaling function of beta-catenin and thus to carcinogenesis. We then analyzed human HCCs and found similar mutations in eight of 31 (26%) human liver tumors tested and in HepG2 and HuH6 hepatoma cells. The mutations led to the accumulation of beta-catenin in the nucleus. Thus alterations in the beta-catenin gene frequently are selected for during liver tumorigenesis and suggest that disregulation of the Wnt-beta-catenin pathway is a major event in the development of HCC in humans and mice.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/21165/bin/pq1580746001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/21165/bin/pq1580746002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/21165/bin/pq1580746003.gif)
Similar articles
-
Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.Toxicol Pathol. 2005;33(1):175-80. doi: 10.1080/01926230590522130. Toxicol Pathol. 2005. PMID: 15805069 Review.
-
Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.J Gastroenterol Hepatol. 2003 Mar;18(3):280-7. doi: 10.1046/j.1440-1746.2003.02973.x. J Gastroenterol Hepatol. 2003. PMID: 12603528
-
Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.Med Pediatr Oncol. 2002 Nov;39(5):530-5. doi: 10.1002/mpo.10180. Med Pediatr Oncol. 2002. PMID: 12228912 Review.
-
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.Oncogene. 2002 Jul 18;21(31):4863-71. doi: 10.1038/sj.onc.1205591. Oncogene. 2002. PMID: 12101426
-
beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.Int J Oncol. 2000 Jun;16(6):1133-6. doi: 10.3892/ijo.16.6.1133. Int J Oncol. 2000. PMID: 10811985
Cited by
-
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice.BMC Cancer. 2024 Jun 3;24(1):673. doi: 10.1186/s12885-024-12407-2. BMC Cancer. 2024. PMID: 38825709 Free PMC article.
-
How tumors escape the immune system.Elife. 2024 May 14;13:e97881. doi: 10.7554/eLife.97881. Elife. 2024. PMID: 38743056 Free PMC article.
-
Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.PLoS One. 2024 Feb 26;19(2):e0299114. doi: 10.1371/journal.pone.0299114. eCollection 2024. PLoS One. 2024. PMID: 38408048 Free PMC article.
-
Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine.Cancers (Basel). 2023 Dec 19;16(1):12. doi: 10.3390/cancers16010012. Cancers (Basel). 2023. PMID: 38201440 Free PMC article.
-
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2023 Nov 3;10:1955-1971. doi: 10.2147/JHC.S291553. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37941812 Free PMC article. Review.
References
-
- Buendia M A. Adv Cancer Res. 1992;59:167–226. - PubMed
-
- Miller J R, Moon R T. Genes Dev. 1996;10:2527–2539. - PubMed
-
- Peifer M. Science. 1997;275:1752–1753. - PubMed
-
- Barth A, Näthke I S, Nelson W J. Curr Opin Cell Biol. 1997;9:683–690. - PubMed
-
- Behrens J, von Kries J P, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Nature (London) 1996;382:638–642. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous